Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Differences in infection control and diagnostic measures for multidrug-resistant organisms in the tristate area of France, Germany and Switzerland in 2019 – survey results from the RH(E)IN-CARE network

Original article
Tschudin-Sutter S, Lavigne T, Grundmann H, Rauch J, Eichel VM, Deboscker S, Jaulhac B, Mutters NT
Swiss Med Wkly. 2021;151:w20454

Multidrug-resistant organisms are a public health threat. Single-centre interventions, however, are likely to fail in the long term, as patients are commonly transferred between institutions given the economic integration across borders. A transnational approach targeting larger regions is needed to plan overarching sets of interventions.

Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland

Original article
Thiabaud A, Iten A, Balmelli C, Senn L, Troillet N, Widmer A, Flury D, Schreiber PW, Vázquez M, Damonti L, Buettcher M, Vuichard-Gysin D, Kuhm C, Cusini A, Riedel T, Nussbaumer-Ochsner Y, Gaudenz R, Heininger U, Berger C, Zucol F, Bernhard-Stirnemann S, Corti N, Zimmermann P, Uka A, Niederer-Loher A, Gardiol C, Roelens M, Keiser O
Swiss Med Wkly. 2021;151:w20475

In cooperation with the Federal Office of Public Health, a surveillance database was set up in February 2020 to monitor hospitalised patients with COVID-19, in addition to their mandatory reporting system. The surveillance system has been successfully initiated and provides a robust set of data for Switzerland by including about 80% (compared with official statistics) of SARS-CoV-2/COVID-19 hospitalised patients, with similar age and comorbidity distributions. It adds detailed information on the epidemiology, risk factors and clinical course of these cases and, therefore, is a valuable addition to the existing mandatory reporting.

Distribution of low quality filtering facepiece respirators during the COVID-19 pandemic: an independent analysis of the situation in Switzerland

Original article
Delaloye JR, Vernez D, Suarez G, de Courten D, Zingg W, Perret V, Metzger CMJA, Richner G
Swiss Med Wkly. 2021;151:w20459

The demand for FFP respirators exceeded the supply capacity from established suppliers of the Swiss market. New production and import channels emerged, as did the number of poor-quality FFP respirators. FFP respirators remaining in stocks should be checked for conformity before being used, or eliminated and replaced if quality does not meet standards.

In the eye of the hurricane: the Swiss COVID-19 pandemic stepwise shutdown approach in organ donation and transplantation

Original article
Immer F, Benden C, Elmer A, Krügel N, Nyfeler S, Nebiker M, Wilhlem M, Hirzel C, National Committee for Organ Donation (CNDO), Medical Committee (CM) and Swisstransplant Infectious Diseases Working Group (STAI)
Swiss Med Wkly. 2020;150:w20447

The Swiss stepwise shutdown approach in organ donation and transplantation helped to maintain a limited national organ procurement and vital organ transplant activity, avoiding a complete nationwide shutdown of organ donation and transplant activity. 

Impact of the COVID-19 pandemic on acute coronary syndromes

Original article
Perrin N, Iglesias JF, Rey F, Benzakour L, Cimci M, Noble S, Degrauwe S, Tessitore E, Mach F, Roffi M
Swiss Med Wkly. 2020;150:w20448

Prolonged delays from symptom onset to first medical contact and a decline in overall ACS incidence were observed during the first wave of the COVID-19 pandemic, with a higher threshold to call for help among ACS patients.

Towards novel reimbursement models for expensive advanced therapy medicinal products (ATMPs)

Original article
Picecchi D, Bertram K, Brücher D, Bauer M
Swiss Med Wkly. 2020;150:w20355

This article analyses the current legal framework in Switzerland and critically evaluates existing reimbursement models, particularly with respect to their adaptation for advanced therapy medicinal products. As a promising reimbursement arrangement, this paper proposes a model combining outcome-based instalment payments with aspects of the pay for performance and the annuity payment model. 

Crisis of emerging antibiotic resistances mirroring that of the COVID-19 in the age of globalisation

Viewpoint
Nordmann P, Poirel L, Frey J
Swiss Med Wkly. 2020;150:w20402

Like to the COVID crisis, control of emerging antibiotic resistance genes requires early detection, rapid diagnosis, early intervention and development of novel antimicrobial agents. Epidemiological surveillance at the local level for emerging resistance at the molecular and biochemical levels is required.

Ventilatory weaning and early rehabilitation in COVID-19-related acute respiratory distress syndrome: the experience at Locarno hospital, canton of Ticino, Switzerland

Viewpoint
Forni R, Besana T, Amitrano A, Voinea C, Ogna A
Swiss Med Wkly. 2020;150:w20397

The experience presented here, although limited, allows us to draw some important conclusions which may become useful in the current context of increasing numbers of COVID-19 patients needing hospitalisation.

Attitudes and acceptance of patients undergoing visceral surgery towards an open access electronic medical record – a Swiss-German single-centre study

Original article
Bindschädler P, Frei L, Raptis DA, Tschuor C, Breitenstein S
Swiss Med Wkly. 2020;150:w20328

The question of whether patients should have electronic access to their data has become one of the key topics under discussion.

The new remuneration system TARPSY in Swiss psychiatric hospitals: effects on length of stay and readmissions?

Original article
Hepp U, Raim Gautier C, Baumgartner M, Bridler R, Hoff P, Minder J, Müller M, Savaskan E, Seifritz E, Stulz N
Swiss Med Wkly. 2020;150:w20337

If being evident at all, the effects of the new remuneration system TARPSY on LOS and readmission rates seem to be small. Concerns that declining daily rates in TARPSY would result in early discharges and increased readmission rates did not prove true in adult and geriatric psychiatry.

Verpassen Sie keinen Artikel!

close